Bioartificial bone grafting: Tarsal joint fusion in a dog using a bioartificial composite bone graft consisting of beta-tricalciumphosphate and platelet rich plasma--a case report

Vet Comp Orthop Traumatol. 2005;18(1):52-4.

Abstract

Grafting of large bone defects caused by trauma or tumor resection still remains a problem to solve. In experimental studies as well as in human dentistry, osteoconduction and biodegradation of the beta-tricalciumphosphate Cerasorb as well as osteoinductive capabilities of platelet rich plasma have been proven. In case of luxation of the right tarsal joint, including a compressive fracture of the forth tarsal bone, the recommended use of autologous cancellous bone to support osseous fusion was replaced by the use of a bioartificial bone graft. Biodegradation of the bone graft was proven clinically and radiographically. Complete osseous fusion of the intertarsal joint occurred. The use of the beta-tricalciumphosphate Cerasorb in combination with platelet rich plasma to support a partial arthrodesis of the tarsal joint in a dog did not impede the healing process but led to full recovery of the patient, indicating that this concept of bioartificial bone grafting could support bone healing.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Blood Platelets
  • Bone Plates / veterinary
  • Bone Substitutes / administration & dosage*
  • Bone Transplantation / veterinary
  • Calcium Phosphates / administration & dosage
  • Dogs / injuries*
  • Dogs / surgery
  • Female
  • Joint Instability / diagnostic imaging
  • Joint Instability / surgery
  • Joint Instability / veterinary*
  • Radiography
  • Tarsus, Animal / diagnostic imaging
  • Tarsus, Animal / injuries*
  • Tarsus, Animal / surgery*

Substances

  • Bone Substitutes
  • Calcium Phosphates
  • beta-tricalcium phosphate